Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026)

Inspire Medical Systems' Total Non-Current Liabilities history spans 10 years, with the latest figure at $119.0 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 25.29% to $119.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $119.0 million, a 25.29% increase, with the full-year FY2025 number at $126.1 million, up 6.34% from a year prior.
  • Total Non-Current Liabilities hit $119.0 million in Q1 2026 for Inspire Medical Systems, down from $126.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for INSP hit a ceiling of $141.1 million in Q3 2025 and a floor of $57.2 million in Q3 2022.
  • Historically, Total Non-Current Liabilities has averaged $95.3 million across 5 years, with a median of $95.2 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 2.22% in 2022 and later soared 66.46% in 2023.
  • Tracing INSP's Total Non-Current Liabilities over 5 years: stood at $68.7 million in 2022, then surged by 49.81% to $103.0 million in 2023, then increased by 15.14% to $118.5 million in 2024, then increased by 6.34% to $126.1 million in 2025, then decreased by 5.62% to $119.0 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for INSP at $119.0 million in Q1 2026, $126.1 million in Q4 2025, and $141.1 million in Q3 2025.